- CFO Spotlights
- Profiles
- Brian Stephenson
Profile
Brian Stephenson
Chief Financial Officer, Sensei Biotherapeutics, Inc.
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
Brian Stephenson has been Chief Financial Officer of Sensei Biotherapeutics, Inc. since June 13, 2026, according to the company's filing of June 15, 2026.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| Sensei Biotherapeutics, Inc. (SNSE) Pharmaceutical Preparations | Chief Financial Officer | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- June 13, 2026effective
Sensei Biotherapeutics, Inc. appointed Brian Stephenson as Chief Financial Officer, effective June 13, 2026.
Effective as of June 13, 2026, Brian Stephenson was appointed as the Company’s Chief Financial Officer and principal financial officer.
[1] Filing by Sensei Biotherapeutics, Inc., filed with the SEC on June 15, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Current report filed with the SEC, Sensei Biotherapeutics, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed June 15, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Brian Stephenson wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.